James S. Burns has over 30 years executive experience in the pharmaceutical, biotechnology, and diagnostic fields. He has served in leadership roles ranging from commercialization, financial, business development, and general management within businesses ranging from early-stage companies to large multinational corporations, venture capital, and private equity. Prior to joining AssureRx, Jim has served as President and CEO of EntreMed, a public clinical-stage pharmaceutical company developing drugs for the treatment of cancer and inflammatory diseases; as President, EVP and a founder of MedPointe Pharmaceuticals, a specialty branded pharmaceutical company; a founder and Managing Director of MedPointe Capital, a private equity firm; President, CEO and a founder of Osiris Therapeutics, a public biotech company specializing in stem cell therapy for the treatment of damaged or diseased tissues; a founding General Partner of HealthCare Ventures LP, a venture capital partnership specializing in forming new pharmaceutical and biotech companies; Group President at Becton Dickinson, a global diagnostic and medical device company; and Partner at Booz Allen Hamilton, a global strategy and technology consultant.
